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Walter J. Paulus, MD, PHD,y Loek van Heerebeek, MD, PHDyzE xercise intolerance due to dyspnea or musclefatigue is the most common clinical symptomin heart failure with preserved ejection frac-
tion (HFpEF). Improvement of exercise tolerance is
therefore correctly used as the primary endpoint in
recent HFpEF trials. In this issue of the Journal,
Borlaug et al. (1) report on invasively established
improvement of exercise hemodynamics when HFpEF
patients received an intravenous infusion of sodium
nitrite before the exercise stress test.SEE PAGE 1672Inorganic nitrite originates from the reduction of
inorganic nitrate, a compound known since ancient
times as gunpowder. In the human body, both inor-
ganic nitrate and nitrite are converted to nitric oxide
(NO), with nitrate requiring 2 reductions and nitrite
only 1 reduction (2). In contrast to organic nitrates,
tolerance does not develop because there is no need
for enzymatic separation from small carbon-based
molecules (2). The improvement of exercise toler-
ance observed by Borlaug et al. (1) was evident at a
comparable workload from a lower pulmonary capil-
lary wedge pressure (PCWP), pulmonary artery pres-
sure, and systemic vascular resistance (SVR), as well
as from increased cardiac output (CO), left ventricular
stroke work (LVSW), oxygen consumption (VO2), and
slope of the DCO/DVO2 relation (exercise factor).*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
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hemodynamics are consistent with novel insights on
inadequate myocardial availability of NO and cyclic
guanosine monophosphate (cGMP) in HFpEF (3,4).
EXERCISE INTOLERANCE AND NITRITE
High left ventricular (LV) diastolic stiffness, LV systolic
shortening deﬁcit, chronotropic incompetence, and
deﬁcient pulmonary or systemic vasodilation have all
been proposed as mechanisms critically limiting ex-
ercise tolerance in HFpEF (5,6). Their involvement in
the beneﬁcial effect of nitrite deserves closer scrutiny.
First among the proposed mechanisms for exercise
intolerance in HFpEF is high LV diastolic stiffness (5),
which elicits a prompt and large increase in PCWP (7),
even at low-level exercise, as illustrated in the study
by Borlaug et al. (1). High LV diastolic stiffness results
from a modest deposition of interstitial collagen and
from cardiomyocytes with a less distensible cyto-
skeletal protein titin (4,8,9). Low titin distensibility
is presumed to derive from hypophosphorylation
by protein kinase G (PKG), a presumption supported
by in vitro experiments in which PKG administration
corrects distensibility of isolated HFpEF cardiomyo-
cytes and by the presence in HFpEF myocardium of
low PKG activity and an impressive 10-fold reduction
of the concentration of cGMP, the cofactor of PKG (3).
The low cGMP concentration derives from deﬁcient
upstream activation of soluble guanylate cyclase by
NO and of particulate guanylate cyclase by natriuretic
peptides. In HFpEF myocardium, both NO and natri-
uretic peptide contents are low, respectively, because
of microvascular endothelial inﬂammation induced
by comorbidities and because of low wall stress in a
concentrically remodeled left ventricle (3,4). In the
absence of LV volume measurements, the current
study (1) did not directly assess diastolic LV stiffness.
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1684The large increase after nitrite infusion in exercise LV
stroke volume (7 ml), however, strongly suggests
improvement of LV diastolic stiffness with lower
PCWP (11 mm Hg) at comparable or larger LV end-
diastolic volumes. In HFpEF, increased LV stroke
volume is more likely to arise from a larger end-
diastolic volume than from a smaller LV end-systolic
volume because of high end-systolic elastance,
which only allows for limited end-systolic volume
reductions during LV unloading or positive inotropic
interventions. Increased NO delivery, replenished
cGMP stores, and restored PKG-mediated destiffeningFIGURE 1 Exercise Intolerance and Microvascular Dysfunction
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Titin-PO4 ¼ titin phosphorylation.of titin can explain the improved LV diastolic stiff-
ness after nitrite infusion. Nitrite infusion apparently
did not improve LV diastolic stiffness at rest given
that the small reduction in PCWP (3 mm Hg) was
accompanied by a reduced LV stroke volume (5 ml).
The difference between exercise and rest is compat-
ible with nitrite administration delivering more NO to
the myocardium during exercise than at rest because
of the presence of myocardial hypoxia, which boosts
conversion of nitrite to NO.
The drastic reduction of cGMP in HFpEF myocar-
dium is also relevant to the LV systolic shortening(CaO2 - CvO2)EX
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1685deﬁcit frequently reported in HFpEF, both at rest and
during exercise (6). The dose-response curve for
cGMP and cardiac muscle contractile performance has
an ascending and descending limb explained by
competing effects of cGMP on calcium handling and
myoﬁlamentary desensitization (10). At the very low
cGMP levels observed in HFpEF myocardium, the
cardiomyocytes could well be operating on the
ascending limb of the dose-response curve with a
concomitant LV systolic shortening deﬁcit and the
large increase in LVSW during exercise after nitrite
infusion could be consistent with increased myocar-
dial cGMP eliciting a move up the ascending limb.
Another mechanism recently suggested to con-
tribute to exercise intolerance in HFpEF is chrono-
tropic incompetence (6). Evidence suggests that
chronotropic incompetence not only reduces CO
during exercise because of a blunted heart rate
response, but also forces the left ventricle at the onset
of exercise to use its preload reserve because the
surge in venous return is not matched by an appro-
priate increase in heart rate. The latter phenomenon
profoundly impairs exercise tolerance in transplant
recipients. In the current study, there was no differ-
ence in the heart rate response to exercise, suggesting
that chronotropic incompetence does not seem to
be involved in the effects of nitrite on exercise
tolerance.
Deﬁcient pulmonary and systemic vasodilation
have also been implicated in HFpEF exercise intol-
erance (11–13). Patients with exertional pulmonary
venous hypertension have a limited ability to lower
pulmonary vascular resistance (PVR) during exercise
and one-third of patients even experience a para-
doxical increase in PVR (11). The current study (1)
observed a similar inability to lower PVR, which
unfortunately remained unaffected by a previous
nitrite infusion. Patients in both studies share an
important clinical characteristic: obesity, with an
average body mass index of 33 kg/m2. Obesity and
metabolic syndrome are known to cause microvas-
cular inﬂammation, reduced density of the micro-
vascular network (i.e., microvascular rarefaction),
and increased PVR. In obese HFpEF patients, micro-
vascular inﬂammation and rarefaction not only af-
fect the pulmonary circulation but also the systemiccirculation. This produces impaired oxygen delivery
to exercising muscles, as evident by a smaller arte-
riovenous oxygen content difference (CaO2  CvO2)
(12). The present study partially conﬁrms the im-
portance of blunted muscle perfusion for exercise
intolerance in HFpEF as it observed lower SVR
and higher VO2 but unaltered CaO2  CvO2 after nitrite
infusion.
EXERCISE INTOLERANCE AND
MICROVASCULAR DYSFUNCTION
Microvascular dysfunction induced by comorbidities
appears to be a common denominator for most of the
mechanisms responsible for exercise intolerance in
HFpEF as it is involved in high LV diastolic stiffness,
LV systolic shortening deﬁcit, and blunted pulmonary
or systemic vasodilation (Figure 1). It is also involved
in renal sodium retention because low renal NO con-
tent shifts the renal perfusion pressure–natriuresis
curve to the right. The extent of microvascular dys-
function in pulmonary, systemic, coronary, and renal
beds probably varies in relation to the duration of
HFpEF or comorbidity proﬁle. This supports the
hemodynamic evaluation of exercise intolerance in
individual HFpEF patients to guide personalized
treatment, as illustrated in this new study (1), which
showed nitrite improved PCWP, CO, and LVSW but not
PVR and CaO2  CvO2 during exercise.
CONCLUSIONS
Borlaug et al. (1) deserve to be commended for the
current study. It demonstrates the clinical relevance
of invasive exercise hemodynamics before assigning
HFpEF patients to therapy, establishes inorganic ni-
trite as acutely improving exercise hemodynamics in
HFpEF, and, because inorganic nitrite lacks tolerance
development, paves the way for its use in long-term
HFpEF trials.
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